Comparison of Efficacy and Safety of First-line Transplacental Treatment of Fetal Supraventricular Tachycardia (SVT) and Atrial Flutter (AF) with Sotalol, Flecainide and Digoxin

被引：0
|
作者：
Jaeggi, Edgar T.
Carvalho, Julene S.
De Groot, Ernestine
Api, Olus
Clur, Sally-Ann
Manlhiot, Cedric
McCrindle, Brian W.
Rammeloo, Lukas
Blom, Nico A.
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Royal Brompton Hosp, London SW3 6LY, England
[3] Leiden Univ, Med Cntr, Leiden, Netherlands
[4] Acad Med Cntr, Amsterdam, Netherlands
[5] Free Univ Amsterdam, Med Cntr, Amsterdam, Netherlands
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Arrhythmias; treatment of; Supraventricular tachycardia; Atrial flutter; Pregnancy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A20644
引用
收藏
页数：2
相关论文
共 29 条
  • [21] EFFICACY AND SAFETY OF FIRST-LINE TREATMENTS FOR PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND INDIRECT TREATMENT COMPARISON
    Yu, Y.
    Zhu, F.
    Zhang, W.
    Lu, S.
    VALUE IN HEALTH, 2022, 25 (07) : S309 - S309
  • [22] The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy
    Huang, Jiwei
    Su, Ruopeng
    Chen, Zeyu
    Jiang, Shuai
    Chen, Minfeng
    Yuan, Yichu
    Hu, Hailong
    Fu, Changde
    Huang, Zhiyang
    Wang, Zhenyu
    Zheng, Bing
    Li, Chancan
    Wang, Zaoyu
    Bao, Yige
    Cai, Ming
    Guo, Jianming
    Wei, Qiang
    Xue, Wei
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [23] A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
    Fu, Jie
    Yan, Yi-Dan
    Wan, Xu
    Sun, Xiao-Fan
    Ma, Xiu-Mei
    Su, Ying-Jie
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [24] Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
    Yang, Yanqing
    Chen, Wei
    Dong, Lixian
    Duan, Lian
    Gao, Pengfei
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (10): : 2488 - 2502
  • [25] Efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO plus RELA) versus NIVO plus ipilimumab (NIVO plus IPI) in advanced melanoma: An updated indirect treatment comparison (ITC)
    Schadendorf, Dirk
    Tawbi, Hussein A.
    Lipson, Evan J.
    Hodi, F. Stephen
    Ascierto, Paolo Antonio
    Larkin, James
    Lao, Christopher D.
    Grob, Jean-Jacques
    Ejzykowicz, Flavia
    Palaia, Jennell
    Horton, Viviana Garcia
    Zhou, Zheng-Yi
    Christensen, Dana
    Rosenblatt, Lisa
    McDonald, Laura
    Ratto, Barbara
    Salvatore, Anthony
    Patel, Divya
    Sakkal, Leon A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO plus RELA) versus NIVO plus ipilimumab (NIVO plus IPI) in advanced melanoma: An indirect treatment comparison (ITC) using patient-level data (PLD)
    Schadendorf, Dirk
    Tawbi, Hussein A.
    Lipson, Evan J.
    Hodi, F. Stephen
    Ascierto, Paolo Antonio
    Larkin, James
    Lao, Christopher D.
    Grob, Jean-Jacques
    Ejzykowicz, Flavia
    Moshyk, Andriy
    Horton, Viviana Garcia
    Zhou, Jenny
    Xin, Yiqiao
    Palaia, Jennell
    McDonald, Laura
    Keidel, Sarah
    Salvatore, Anthony
    Sakkal, Leon A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis
    Wang, Yanrong
    Li, Lingling
    Hu, Jia
    Zhao, Yan
    Yan, Huan
    Gao, Ming
    Yang, Xuejiao
    Zhang, Xia
    Ma, Junxun
    Dai, Guanghai
    BMC CANCER, 2023, 23 (01)
  • [28] Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis
    Yanrong Wang
    Lingling Li
    Jia Hu
    Yan Zhao
    Huan Yan
    Ming Gao
    Xuejiao Yang
    Xia Zhang
    Junxun Ma
    Guanghai Dai
    BMC Cancer, 23
  • [29] Re: Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. L. B. van der Heijden, M. A. Oudijk, G. Manten, H. ter Heide, L. Pistorius and M. W. Freund. Ultrasound Obstet Gynecol 2013; 42: 285-293
    Strasburger, J. F.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (03) : 254 - 255
123